Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 548 of 6351
-
New drug combo aims to keep bladder cancer from coming back
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (Disitamab Vedotin) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder,…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo aims to save bladders in cancer fight
Disease control Not yet recruitingThis is a phase II clinical study to evaluate the efficacy of RC48-ADC combined with toripalimab bladder-sparing therapy. The RC48-ADC dose in this study is 2.0 mg/kg Q2W and toripalimab is 3 mg/kg Q2W. This study plans to enroll 59 participants. The participants will start dru…
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One-Time radiation procedure could transform cervical cancer care
Disease control Not yet recruitingBackground and Rationale: Locally advanced cervical cancer remains a major public health concern worldwide and in France. Standard-of-care management involves concurrent chemoradiotherapy followed by brachytherapy, which is critical for local tumour control and survival. Convent…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Real-time DNA test during brain surgery could help remove more cancer
Diagnosis Not yet recruitingThis is a single-site, single-arm, prospective, interventional cohort study using intraoperative ultra-rapid droplet digital polymerase chain reaction (UR- ddPCR) to assess residual IDH1-mutant tumor at the end of surgical resection and, if positive, guide additional resection in…
Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New cell therapy aims to make mismatched donor transplants safer for blood cancer patients
Disease control Recruiting nowThe study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for IBD patients: IL-23 blocker aims for Steroid-Free remission
Disease control Recruiting nowPatients diagnosed with moderate to severe CD or UC by the end of the study period were selected. After obtaining informed consent, treatment with infliximab-based drugs was initiated. Basic patient information and medical history were collected. The treatment process was followe…
Phase 4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Timing is everything: new trial tests surgery before or after immunotherapy for kidney cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the timing of surgery (cytoreductive nephrectomy) improves outcomes when combined with immunotherapy (ipilimumab and nivolumab) in adults with metastatic clear cell renal cell carcinoma. The main questions this study aims to an…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy targets blood cancer relapse
Disease control Not yet recruitingThis is a French multicenter open label non-randomized Phase II trial evaluating the efficacy and tolerance of a combination of oral zanubrutinib and BGB-11417 in subjects aged 18 years and older with previously treated Waldenström macroglobulinemia (WM) who require therapy accor…
Phase 2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI breakthrough: predicting breast Cancer's next move
Knowledge-focused Recruiting nowBreast cancer is one of the most common malignancies in women worldwide, and distant metastasis is the main cause of poor prognosis and death. This project aims to construct a precision prediction system based on multi-omics (digital pathology, immunohistochemistry, proteomics, g…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Promising drug trodelvy tested as first defense against aggressive breast cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the drug Sacituzumab govitecan (SG) reduces disease progression when used as a first-line treatment in adults with advanced triple-negative breast cancer (TNBC) who have not received prior treatments in the advanced setting. It will …
Phase 2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis study is an open-label, controlled, multicenter phase III clinical trial designed to evaluate whether the use of iodine-125 radioactive seed markers can improve treatment response for patients with early or locally advanced breast cancer undergoing neoadjuvant therapy. Neoa…
Phase 3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Stem cells injected twice may finally quench cancer survivors' dry mouth
Disease control Not yet recruitingDry mouth leads to debilitating symptoms 24/7. The two primary causes for dry mouth are Sjögrens disease and after radiotherapy of a head and neck cancer. Former clinical trials have investigated mesenchymal stem cell treatment for dry mouth with promising results. However, few o…
Phase 2 • Sponsor: Christian von Buchwald • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for rare liver disease: phase 3 trial of CS0159 launches
Disease control Recruiting nowA Randomized, Double-Blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of CS0159 in Patients with Primary Biliary Cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid (UDCA).
Phase 3 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Lung cancer patients get a second chance: new cell combo aims to stop return of disease
Disease control Recruiting nowThis study evaluates the preliminary efficacy and safety of adjuvant therapy with liquid tumor-infiltrating lymphocytes (L-TIL) in combination with tislelizumab in patients with resectable stage II-IIIB non-small cell lung cancer (NSCLC) who underwent surgery after neoadjuvant tr…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New ventilator method may save fragile preemies from breathing tubes
Disease control Recruiting nowMany extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant…
Sponsor: Michelle Baczynski • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail aims to wipe out lingering leukemia
Disease control Not yet recruitingThe purpose of this study is to explore the efficacy and safety of sorafenib combined with venetoclax as pre-emptive therapy strategy for measurable residual disease persisting acute myeloid leukemia.
Phase 2/3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy aims to tame tough esophageal cancer
Disease control Recruiting nowThis study aims to compare the efficacy and safety of short-course definitive concurrent chemoradiotherapy plus immunotherapy followed by immunotherapy maintenance versus short-course definitive chemoradiotherapy plus immunotherapy maintenance in the treatment of locally advanced…
Phase 2 • Sponsor: Ning Jiang, M.D./Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Heart failure hope for kids: diabetes drug tested as new therapy
Disease control Recruiting nowthe study to investigate the efficacy of empagiflozin in pediatric heart failure
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
Knowledge-focused Recruiting nowThis study aims to investigate the neurophysiological and inflammatory changes associated with electroconvulsive therapy (ECT) in older age patients diagnosed with Major Depressive Episode, Major Depression, and Bipolar Disorder, using microstate analysis derived from resting-sta…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Herbal granules may offer new hope for aging kidneys
Disease control Recruiting nowThis prospective real-world study will evaluate the clinical benefits of Niaoduqing Granules in older adults with impaired kidney function. Approximately 300 participants aged over 60 years with stage 3 to 5 chronic kidney disease who are not receiving dialysis will be enrolled a…
Phase 4 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC